Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Harald Murck"'
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 35, Iss , Pp 100717- (2024)
Recent observations suggest a role of the volume of the cerebral ventricle volume, corpus callosum (CC) segment volume, in particular that of the central-anterior part, and choroid plexus (CP) volume for treatment resistance of major depressive disor
Externí odkaz:
https://doaj.org/article/ab8b3a6f568e419db93333e77edf1490
Publikováno v:
Nutrients, Vol 16, Iss 4, p 515 (2024)
We have previously identified that low responsiveness to antidepressive therapy is associated with higher aldosterone/cortisol ratio, lower systolic blood pressure, and higher salt preference. Glycyrrhiza glabra (GG) contains glycyrrhizin, an inhibit
Externí odkaz:
https://doaj.org/article/d94710d8aaa146d8aaa88ceb48bcac5a
Autor:
Harald Murck, Lisa Lehr, Johannes Hahn, Matthias C. Braunisch, Daniela Jezova, Maxim Zavorotnyy
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Mineralocorticoid-receptor (MR) dysfunction as expressed by low systolic blood pressure and a high salivary aldosterone/cortisol ratio predicts less favorable antidepressant treatment outcome. Inhibition of peripheral 11-beta-hydroxysteroid-dehydroge
Externí odkaz:
https://doaj.org/article/ce46223b86b14a189761c4afee53b0b3
Autor:
Harald Murck
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The role of the ACE2 enzyme in the COVID-19 infection is 2-fold, with opposing implications for the disease development. 1. The membrane bound angiotensin converting enzyme 2 (ACE2) serves as the entry point of COVID-19 2. Conversely, it supports an
Externí odkaz:
https://doaj.org/article/3c12116ccece46d99dc20d93f691e307
Publikováno v:
Nutrients, Vol 13, Iss 7, p 2321 (2021)
Angiotensin converting enzyme 2 (ACE2) is a key entry point of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus known to induce Coronavirus disease 2019 (COVID-19). We have recently outlined a concept to reduce ACE2 expression by th
Externí odkaz:
https://doaj.org/article/27222673b3964179bc395b57ffeed835
Recent observations suggest a role of the choroid plexus (CP) and cerebral ventricle volume (CV), to identify treatment resistance of major depressive disorder (MDD). We tested the hypothesis that these markers are associated with clinical improvemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa318b1393886010e4737bbca7b20c8
https://doi.org/10.21203/rs.3.rs-2618151/v1
https://doi.org/10.21203/rs.3.rs-2618151/v1
Publikováno v:
Journal of Neuroendocrinology. 35
An abundance of knowledge has been collected describing the involvement of neuroendocrine parameters in major depression. The hypothalamic-pituitary-adrenocortical (HPA) axis regulating cortisol release has been extensively studied; however, attempts
Autor:
Harald Murck, Lisa Lehr
Publikováno v:
Biological Psychiatry. 93:S298
Autor:
Marianne B. Müller, Stefanie Wagner, Jan Engelmann, Giulia Treccani, Klaus Lieb, David P. Herzog, André Tadić, Nadine Dreimüller, Harald Murck
Publikováno v:
Journal of Psychiatric Research. 139:150-158
Major depressive disorder (MDD) is a highly heterogeneous disorder, which may partly explain why treatment outcome using antidepressants is unsatisfactory. We investigated the onset of depression as a possible clinical marker for therapy response pre
Autor:
Katrin Ritzel, Daniel A. Heinrich, Heike E. Künzel, Christian Adolf, Lisa Sturm, Lena Schlageter, Martin Reincke, Anna Schneider, Harald Murck, Felix Beuschlein, Marcus Quinkler
Publikováno v:
Journal of Psychiatric Research. 137:376-382
The mineralocorticoid receptor (MR) and its ligand aldosterone have been found to play a major role in the pathophysiology of depression. Both could be targets of therapeutic interventions. We analyzed laboratory data and questionnaires evaluating an